Identifying and validating pre-clinical biomarkers for diagnostics and therapeutics of Neuromuscular Disorders

“The rapidly expanding knowledge of NMDs genetic diagnosis, pathogenesis and therapeutic possibilities has provided new targets for disease characterisation, early diagnosis, drug discovery and development as well as has raised many questions about how to translate this knowl… [End date:30/11/2012] URI:http://cordis.europa.eu/project/rcn/93293_en.html

Share

Leave a Reply